06.04.2011 - Merck & Co said on Tuesday it would acquire eye treatment maker Inspire Pharmaceuticals for about $430 million to expand its ophthalmology business. Inspire's key product is...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)